Tech Company Financing Transactions
Morphotek Funding Round
On 10/12/2006, Morphotek raised $40 million in Series D financing from Investor Growth Capital, Burrill & Company and CB Health Ventures.
Transaction Overview
Company Name
Announced On
10/12/2006
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series D
Investors
Investor Growth Capital (Lead Investor) (Sunny Sharma)
MDS Capital (Benjamin Rovinski)
Proceeds Purpose
The funds will be used primarily to further clinical development of the Company's lead therapeutic antibodies, MORAb-003 and MORAb-009, and to advance its pipeline of preclinical antibodies for the treatment of oncology, inflammatory and infectious diseases.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
210 Welsh Pool Road
Exton, PA 19341
USA
Exton, PA 19341
USA
Phone
Website
Email Address
Not Recorded
Overview
Morphotek is a biopharmaceutical company developing therapeutic monoclonal antibodies through the use of a proprietary human antibody technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicholas Nicolaides
Browse more venture capital transactions:
Prev: 10/10/2006: Achaogen venture capital transaction
Next: 10/12/2006: Greystripe venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs